FLUTICASONE FUROATE 100 MCG +VILANTEROL 25MCG

BRAND NAME : RESVILA DPI CAP
COMPOSITION : FLUTICASONE FUROATE 100 MCG +VILANTEROL 25MCG
PACKING : 15 CAPSULES

FLUTICASONE FUROATE 100 MCG +VILANTEROL 25MCG

RESVILA DPI CAPS is an advanced once-daily Dry Powder Inhaler (DPI) therapy designed for the effective management of asthma and chronic obstructive pulmonary disease (COPD). This formulation combines Fluticasone Furoate, a potent anti-inflammatory corticosteroid, with Vilanterol, a long-acting beta-2 agonist (LABA), providing extended relief from respiratory symptoms and improving lung function.

Composition:

  • Fluticasone Furoate 100 mcg: A highly effective corticosteroid that reduces airway inflammation and prevents exacerbations.
  • Vilanterol 25 mcg: A LABA that provides sustained bronchodilation for improved breathing throughout the day.

Packing:

  • 15 Capsules Per Pack – A convenient 15-day supply for continued respiratory care.

Key Features of RESVILA DPI CAPS

  • Once-Daily Dosing: Simplifies treatment regimen while providing 24-hour symptom control.
  • Dual Action Relief: Combines anti-inflammatory and bronchodilating effects for comprehensive respiratory management.
  • Convenient DPI Format: Ensures precise dosing and easy administration for patient compliance.

Indications:

  • Maintenance treatment of asthma in patients requiring long-term control of airway inflammation and bronchoconstriction.
  • Management of moderate to severe COPD, including chronic bronchitis and emphysema.
  • Prevention of exacerbations in chronic respiratory diseases.

Benefits of RESVILA DPI CAPS

  1. 24-Hour Control: Provides round-the-clock relief from respiratory symptoms.
  2. Improved Quality of Life: Enhances breathing comfort and reduces the frequency of flare-ups.
  3. User-Friendly Design: Lightweight, portable, and easy to use for all age groups.

Dosage and Administration:

  • 1 Capsule Once Daily via a dry powder inhaler device or as prescribed by a healthcare professional.
  • Regular use is essential for optimal results; do not exceed the prescribed dosage.

Why Choose RESVILA DPI CAPS?

  • An advanced, trusted solution for long-term asthma and COPD management.
  • Reduces the need for frequent inhalations, ensuring better compliance.
  • Scientifically proven to improve lung function and overall respiratory health.
Scroll to Top